Valuation: Medline Inc.

Capitalization 35.57B 30.67B 27.69B 26.57B 48.45B 3,269B 50.7B 327B 131B 1,568B 134B 131B 5,607B P/E ratio 2026 *
44.7x
P/E ratio 2027 * 36.3x
Enterprise value 45.03B 38.83B 35.05B 33.63B 61.33B 4,139B 64.18B 414B 166B 1,985B 169B 165B 7,098B EV / Sales 2026 *
1.46x
EV / Sales 2027 * 1.31x
Free-Float
-
Yield 2026 *
0.31%
Yield 2027 * 0.35%
1 day-0.50%
1 week-7.75%
Current month-7.75%
1 month-7.34%
Current year+4.36%
1 week 42.6
Extreme 42.6
47.41
1 month 42.6
Extreme 42.6
50.88
Current year 38.5
Extreme 38.5
50.88
1 year 34.89
Extreme 34.89
50.88
3 years 34.89
Extreme 34.89
50.88
5 years 34.89
Extreme 34.89
50.88
10 years 34.89
Extreme 34.89
50.88
Change 5d. change 1-year change 3-years change Capi.($)
-0.50%-7.75% - - 35.57B
-1.33%-5.84%-20.11%+9.58% 190B
-2.27%-6.92%-3.81%+14.00% 117B
-0.23%-3.68%+40.80%+133.97% 69.73B
+1.31%+0.87%+64.51%+103.21% 60.92B
-1.66%-5.30%-27.19%-29.23% 47.59B
-3.66%-7.26%-12.51%-40.16% 26.21B
-3.35%-8.65%-0.96%+26.87% 22.61B
+4.33%-2.32%-23.13%+13.46% 19.29B
-3.26%-10.10%-14.76%-47.12% 18.57B
Average -1.06%-5.47%+0.32%+20.51% 60.76B
Weighted average by Cap. -1.15%-5.30%+0.24%+29.08%

Financials

2026 *2027 *
Net sales 30.9B 26.64B 24.05B 23.08B 42.08B 2,840B 44.04B 284B 114B 1,362B 116B 113B 4,870B 33.24B 28.66B 25.87B 24.82B 45.26B 3,054B 47.37B 306B 123B 1,465B 125B 122B 5,239B
Net income 1.43B 1.24B 1.12B 1.07B 1.95B 132B 2.04B 13.19B 5.29B 63.2B 5.38B 5.27B 226B 1.77B 1.53B 1.38B 1.32B 2.41B 163B 2.52B 16.3B 6.53B 78.07B 6.65B 6.51B 279B
Net Debt 9.46B 8.15B 7.36B 7.06B 12.88B 869B 13.48B 87.03B 34.86B 417B 35.5B 34.74B 1,491B 7.82B 6.74B 6.08B 5.84B 10.65B 718B 11.14B 71.92B 28.81B 344B 29.34B 28.71B 1,232B
Date Price Change Volume
06/03/26 43.83 $ -0.50% 17,831,082
05/03/26 44.05 $ +2.73% 43,769,017
04/03/26 42.88 $ -3.40% 4,952,819
03/03/26 44.39 $ -3.18% 4,444,193
02/03/26 45.85 $ -3.49% 2,102,358
Trader
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
43.83USD
Average target price
52.80USD
Spread / Average Target
+20.47%

Quarterly revenue - Rate of surprise